SELLAS Life Sciences SLS
NASDAQ SLS
$13.85 +0.15 (+1.13%)
As of: Sep 4, 2026 · 3:59 PM EDT

SELLAS Life Sciences (SLS) Treasury Shares (2010 - 2017)

SELLAS Life Sciences (SLS) posted quarterly Treasury Shares of $3.8 million for Q3 2017, little changed year-over-year from $3.8 million in Q3 2016, and little changed quarter-over-quarter from $3.8 million in Q2 2017.

Analysis

SELLAS Life Sciences (SLS) Treasury Shares (2010 - 2017) Analysis & Trends

SELLAS Life Sciences (SLS) has reported Treasury Shares for 8 consecutive years, with $3.8 million the latest figure, recorded in Q3 2017.

  • In Q3 2017, Treasury Shares changed 0.0% year-over-year to $3.8 million; the TTM figure through Sep 2017 stood at $3.8 million (changed 0.0% YoY), while the FY2016 annual figure was $3.8 million, changed 0.0% from the prior year.
  • Treasury Shares steadied at $3.8 million in Q3 2017 per SLS's latest filing, from $3.8 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.3 million in Q1 2026 and bottomed at $255000.0 in Q4 2022.
  • Historically, Treasury Shares has averaged $799411.8 across 5 years, with a median of $472000.0 in 2024.
  • On a YoY basis, Treasury Shares climbed as much as 0.0% in 2013 and fell as far as 0.0% in 2013.
  • SELLAS Life Sciences' Treasury Shares stood at $3.8 million in 2013, then changed by 0.0% to $3.8 million in 2014, then changed by 0.0% to $3.8 million in 2015, then changed by 0.0% to $3.8 million in 2016, then changed by 0.0% to $3.8 million in 2017.
  • Business Quant data shows SLS's Treasury Shares at $3.8 million in Q3 2017, $3.8 million in Q2 2017, and $3.8 million in Q1 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 2.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 SELLAS Life Sciences 2.62 Bn 2.62 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 33,750.00
Sep 30, 2017 3.85 Mn
Sep 30, 2017 3.85 Mn
Sep 30, 2017 33,750.00
Jun 30, 2017 33,750.00
Jun 30, 2017 3.85 Mn
Jun 30, 2017 3.85 Mn
Jun 30, 2017 33,750.00
Mar 31, 2017 3.85 Mn
Mar 31, 2017 675,000.00
Mar 31, 2017 675,000.00
Mar 31, 2017 3.85 Mn
Dec 31, 2016 3.85 Mn
Dec 31, 2016 33,750.00
Dec 31, 2016 33,750.00
Dec 31, 2016 3.85 Mn
Sep 30, 2016 3.85 Mn
Sep 30, 2016 3.85 Mn
Sep 30, 2016 675,000.00
Sep 30, 2016 675,000.00